Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies

Liz Kane
Impactful Strategy

Brenda Snow
Authentic Patient Voice

Matthew Durham
Omnidynamic Marketing

Matt Turner
Patient Affordability

Frank Burrell
Scientific Storytelling

Paul Theisen
Patient Acquisition

Suma Ramadas, PhD
Medical Affairs

David Linetsky
Point-of-Care Marketing

Amy Giles
Increasing Engagement

Daniel Sontupe
Market Access

Joey Cohen
Medication Adherence

Stacey Gandler
Brand Nourishment

Pat Purcell
Meeting Engagement

Bud Bilanich
Success Coach